Towards understanding brain-gut-microbiome connections in Alzheimer's disease.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27585440)

Published in BMC Syst Biol on August 26, 2016

Authors

Rong Xu1, QuanQiu Wang2

Author Affiliations

1: Department of Epidemiology and Biostatistics, Institute of Computational Biology, School of Medicine, Case Western Reserve University, 2103 Cornell Road, Cleveland, 44106, USA. rxx@case.edu.
2: ThinTek LLC, Palo Alto, 94306, USA.

Articles cited by this

Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2005) 30.44

Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76

Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98

STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26

The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res (2013) 14.23

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44

HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res (2012) 9.21

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med (2013) 8.21

Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11

Molecular signatures database (MSigDB) 3.0. Bioinformatics (2011) 8.08

Functional interactions between the gut microbiota and host metabolism. Nature (2012) 7.91

Host-gut microbiota metabolic interactions. Science (2012) 7.73

Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med (2011) 5.77

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis (2000) 3.46

Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab (2013) 3.01

Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat Rev Genet (2012) 2.92

STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res (2013) 2.32

Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol (2012) 2.29

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19

Antioxidant potential of ferulic acid. Free Radic Biol Med (1992) 1.95

Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology (2004) 1.73

Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci (2007) 1.65

The Mediterranean diet, its components, and cardiovascular disease. Am J Med (2014) 1.61

Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology (2004) 1.53

Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. J Neurosci (2007) 1.28

Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol (2012) 1.26

Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. Trends Mol Med (2008) 1.03

Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component. Proc Natl Acad Sci U S A (2009) 0.99

Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry (1999) 0.96

Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radic Biol Med (2002) 0.92

Parkin suppresses the expression of monoamine oxidases. J Biol Chem (2006) 0.91

Phenome-driven disease genetics prediction toward drug discovery. Bioinformatics (2015) 0.91

Network-based gene prediction for Plasmodium falciparum malaria towards genetics-based drug discovery. BMC Genomics (2015) 0.91

A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics (2015) 0.90

Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem (1996) 0.90

Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease. AMIA Annu Symp Proc (2015) 0.84

Bioavailability of ferulic acid. Biochem Biophys Res Commun (1998) 0.84

PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discovery. J Biomed Inform (2015) 0.83

Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology (1998) 0.82

Urinary polyamines and N-acetylated polyamines in four patients with Alzheimer's disease as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode. Anal Chim Acta (2006) 0.79

DenguePredict: An Integrated Drug Repositioning Approach towards Drug Discovery for Dengue. AMIA Annu Symp Proc (2015) 0.76